NEW YORK (GenomeWeb News) — Agendia yesterday said it has given Argentine distributor Teva & Tutor exclusive rights to market Agendia's MammaPrint microarray in Argentina and Paraguay.
 
Agendia, based in the Netherlands, said that this South American expansion is part of a larger global sales effort, and said this is "an important step in opening more markets."
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.